Search
for
Sort by
Research 421–450 of 1000+
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- JAK inhibitors in dermatology: The promise of a new drug class
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- The Protective Effect of the Crosstalk between Zinc Hair Concentration and Lymphocyte Count—Preliminary Report
- Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification
- Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases
- 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (TSG) from Polygonum multiflorum Thunb.: A Systematic Review on Anti-Aging
- N,N-Dimethylglycine Sodium Salt Exerts Marked Anti-Inflammatory Effects in Various Dermatitis Models and Activates Human Epidermal Keratinocytes by Increasing Proliferation, Migration, and Growth Factor Release
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities
- Application of microneedle patches for drug delivery; doorstep to novel therapies
- Reversible Activation of c-Myc in Skin
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report
- Botryococcus terribilis Ethanol Extract Exerts Anti-inflammatory Effects on Murine RAW264 Cells
- Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
- The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Hordenine Activated Dermal Papilla Cells and Promoted Hair Regrowth by Activating Wnt Signaling Pathway
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Recent Advances in Drug Development for Hair Loss
- Ayurveda & Bioactives as Adjuvant for Dna Modulation in Cancer Treatment & Adverse Drug Reaction [ADR] – A Glimpse of Traditional Indian Nanotechnology
- A State-of-the-Art Review on Recent Biomedical Application of Polysaccharide-Based Niosomes as Drug Delivery Systems
- Cytochrome P450: A Target for Drug Development for Skin Diseases